FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106442 [Registered on: 17/03/2026] Trial Registered Prospectively
Last Modified On: 17/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Preventive
Screening 
Study Design  Single Arm Study 
Public Title of Study   Effect of Seasonal Herbal Face Application Sharad Ritu Mukhalepa in the Management of Facial Skin Disorders 
Scientific Title of Study   An exploratory study to evaluate the effect of sharad ritu mukhalepa in the management of mukhgat twak vikaras in pitta prakriti purusha  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anita Yadav 
Designation  MD Scholer 
Affiliation  PGIA DSRRAU JODHPUR 
Address  Room 111 PG Department of Swasthavritta and Yoga Post Graduate Institute of Ayurveda Research and Studies Dr Sarvepalli Radhakrishnan Rajasthan Aurveda University Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342037
India 
Phone  7062159735  
Fax    
Email  anyyadav9166@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bramhmanand sharma 
Designation  Associate Professor and Hod  
Affiliation  PGIA DSRRAU JODHPUR 
Address  Room 111 PG Department of Swasthavritta and Yoga Post Graduate Institute of Ayurveda Research and Studies Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342037
India 
Phone  9460318138  
Fax    
Email  bkmudgal9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bramhmanand sharma 
Designation  Associate Professor and Hod  
Affiliation  PGIA DSRRAU JODHPUR 
Address  Room 111 PG Department of Swasthavritta and Yoga Post Graduate Institute of Ayurveda Research and Studies Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342037
India 
Phone  9460318138  
Fax    
Email  bkmudgal9@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University Jodhpur 342037 India 
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurveda DSRRAU Jodhpur 
Address  Post Graduate Institute of Ayurveda Research AND Studies Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University Jodhpur Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ANITA YADAV  Post Graduate Institute of Ayurveda DSRRAU Jodhpur  PG Department of Swasthavritta and Yoga Post Graduate Institute Of Ayurveda Research and Studies Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University Jodhpur Rajasthan
Jodhpur
RAJASTHAN 
7062159735

annyyadav9166@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC PGIA DSRRAU JODHPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L99||Other disorders of skin and subcutaneous tissue in diseases classified elsewhere. Ayurveda Condition: VYANGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Sharad Ritu Mukhalepa, Reference: Asthang hridaya Sutrasthan 22, Route: Topical, Dosage Form: Lepa Churna, Dose: 1(g), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 15 Days, Reference: No, Route: -, Dosage Form: Lepa Churna, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Diagnosis and confirmed cases of Mukhgat Twak Vikaras in Pitta Prakriti Purush as per the screening of Prakriti and sign and symptoms
Patients between the age group of 16 -50 years of irrespective gender, religion, occupation
Patients willing to give written consent
 
 
ExclusionCriteria 
Details  Patients of age below 16 years & above 50years of either sex
Malignant cases of mukhgat twak vikaras
Patients unfit for Lepa like Pinus Ajirna Hanugrah
Patients with side-effects of other medications like Steroids
Patients having domminant vatta and domminant kapha prakriti
Chronic systematic diseases
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the therapeutic and preventive effect of Sharad Ritu mukhalepa in the management of Mukhgat Twak vikaras in the Pitta Parkriti Purush  60 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in subjective and objective parameters  60 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   14/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   1   NO OF PATIENTS 40
2   AGE OF PATIENTS 16 TO 50   Year 
3 Name of Drug  Sharad Ritu Mukhalepa  
4 Duration of Trail 2 month 
5 Route Topically application
6 Type of study  Single arm open labelled study 
7 Follow up after 7 days

 
Close